{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1382825894166559745.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Michael B. Atkins"}],"foaf:familyName":[{"@value":"Atkins"}],"foaf:givenName":[{"@value":"Michael B."}]}],"career":[{"institution":{"notation":[{"@value":"Georgetown‐Lombardi Cancer Center Georgetown University School of Medicine Washington District of Columbia"}]}}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1362825894166559744","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.1002/cam4.106"},{"@type":"URI","@value":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcam4.106"},{"@type":"URI","@value":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.106"},{"@type":"URI","@value":"https://onlinelibrary.wiley.com/doi/full-xml/10.1002/cam4.106"}],"notation":[{"@value":"<scp>PD</scp>‐1 as a potential target in cancer therapy"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1002/cam4.106_DD3518oSqA1tfwXkXDJguKfpxin"}]}